Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization

Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of biological macromolecules 2023-07, Vol.242 (Pt 2), p.124919-124919, Article 124919
Hauptverfasser: Dahiya, Mandeep, Awasthi, Rajendra, Yadav, Jaya Parkash, Sharma, Shammi, Dua, Kamal, Dureja, Harish
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 124919
container_issue Pt 2
container_start_page 124919
container_title International journal of biological macromolecules
container_volume 242
creator Dahiya, Mandeep
Awasthi, Rajendra
Yadav, Jaya Parkash
Sharma, Shammi
Dua, Kamal
Dureja, Harish
description Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines). •Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles.
doi_str_mv 10.1016/j.ijbiomac.2023.124919
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2815246565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0141813023018135</els_id><sourcerecordid>2815246565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</originalsourceid><addsrcrecordid>eNqFkMFu1DAQQC1URJfCL1Q-9pLFEydOwolq1QWkSlzgbI3tCXWU2IudrVS-vi7b9srFY828mdE8xi5BbEGA-jRt_WR8XNBua1HLLdTNAMMbtoG-GyohhDxjGwENVD1Icc7e5zyVrGqhf8fOZQeD6qDbsGl359eYMXCDmRzPMeFIwRtesg8zrsTniK5UFvwdaPWWBwzxgKl8Z8qf-T6m5VhAHwPH4LgP1b1fU-T2DhPalZL_-6_6gb0dcc708TlesF_7m5-7b9Xtj6_fd9e3lZWqX8trpES0RjW9RWeGprYKG0Iy1kkHoxuUGlsiFMK2tlUAXY1OKTPKWlglL9jVae4hxT9HyqtefLY0zxgoHrOue2jrRrWqLag6oTbFnBON-pD8gulBg9BPnvWkXzzrJ8_65Lk0Xj7vOJqF3Gvbi9gCfDkBVC6995R0tp6CJecT2VW76P-34xFaMJVz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2815246565</pqid></control><display><type>article</type><title>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</title><source>Elsevier ScienceDirect Journals</source><creator>Dahiya, Mandeep ; Awasthi, Rajendra ; Yadav, Jaya Parkash ; Sharma, Shammi ; Dua, Kamal ; Dureja, Harish</creator><creatorcontrib>Dahiya, Mandeep ; Awasthi, Rajendra ; Yadav, Jaya Parkash ; Sharma, Shammi ; Dua, Kamal ; Dureja, Harish</creatorcontrib><description>Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines). •Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles.</description><identifier>ISSN: 0141-8130</identifier><identifier>EISSN: 1879-0003</identifier><identifier>DOI: 10.1016/j.ijbiomac.2023.124919</identifier><identifier>PMID: 37196717</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Chitosan nanoparticle ; Cytotoxicity ; Ionic-gelation ; Magnetic nanoparticle ; MTT assay ; Sorafenib</subject><ispartof>International journal of biological macromolecules, 2023-07, Vol.242 (Pt 2), p.124919-124919, Article 124919</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</citedby><cites>FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0141813023018135$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37196717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dahiya, Mandeep</creatorcontrib><creatorcontrib>Awasthi, Rajendra</creatorcontrib><creatorcontrib>Yadav, Jaya Parkash</creatorcontrib><creatorcontrib>Sharma, Shammi</creatorcontrib><creatorcontrib>Dua, Kamal</creatorcontrib><creatorcontrib>Dureja, Harish</creatorcontrib><title>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</title><title>International journal of biological macromolecules</title><addtitle>Int J Biol Macromol</addtitle><description>Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines). •Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles.</description><subject>Chitosan nanoparticle</subject><subject>Cytotoxicity</subject><subject>Ionic-gelation</subject><subject>Magnetic nanoparticle</subject><subject>MTT assay</subject><subject>Sorafenib</subject><issn>0141-8130</issn><issn>1879-0003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkMFu1DAQQC1URJfCL1Q-9pLFEydOwolq1QWkSlzgbI3tCXWU2IudrVS-vi7b9srFY828mdE8xi5BbEGA-jRt_WR8XNBua1HLLdTNAMMbtoG-GyohhDxjGwENVD1Icc7e5zyVrGqhf8fOZQeD6qDbsGl359eYMXCDmRzPMeFIwRtesg8zrsTniK5UFvwdaPWWBwzxgKl8Z8qf-T6m5VhAHwPH4LgP1b1fU-T2DhPalZL_-6_6gb0dcc708TlesF_7m5-7b9Xtj6_fd9e3lZWqX8trpES0RjW9RWeGprYKG0Iy1kkHoxuUGlsiFMK2tlUAXY1OKTPKWlglL9jVae4hxT9HyqtefLY0zxgoHrOue2jrRrWqLag6oTbFnBON-pD8gulBg9BPnvWkXzzrJ8_65Lk0Xj7vOJqF3Gvbi9gCfDkBVC6995R0tp6CJecT2VW76P-34xFaMJVz</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Dahiya, Mandeep</creator><creator>Awasthi, Rajendra</creator><creator>Yadav, Jaya Parkash</creator><creator>Sharma, Shammi</creator><creator>Dua, Kamal</creator><creator>Dureja, Harish</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230701</creationdate><title>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</title><author>Dahiya, Mandeep ; Awasthi, Rajendra ; Yadav, Jaya Parkash ; Sharma, Shammi ; Dua, Kamal ; Dureja, Harish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chitosan nanoparticle</topic><topic>Cytotoxicity</topic><topic>Ionic-gelation</topic><topic>Magnetic nanoparticle</topic><topic>MTT assay</topic><topic>Sorafenib</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dahiya, Mandeep</creatorcontrib><creatorcontrib>Awasthi, Rajendra</creatorcontrib><creatorcontrib>Yadav, Jaya Parkash</creatorcontrib><creatorcontrib>Sharma, Shammi</creatorcontrib><creatorcontrib>Dua, Kamal</creatorcontrib><creatorcontrib>Dureja, Harish</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of biological macromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dahiya, Mandeep</au><au>Awasthi, Rajendra</au><au>Yadav, Jaya Parkash</au><au>Sharma, Shammi</au><au>Dua, Kamal</au><au>Dureja, Harish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</atitle><jtitle>International journal of biological macromolecules</jtitle><addtitle>Int J Biol Macromol</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>242</volume><issue>Pt 2</issue><spage>124919</spage><epage>124919</epage><pages>124919-124919</pages><artnum>124919</artnum><issn>0141-8130</issn><eissn>1879-0003</eissn><abstract>Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines). •Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37196717</pmid><doi>10.1016/j.ijbiomac.2023.124919</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0141-8130
ispartof International journal of biological macromolecules, 2023-07, Vol.242 (Pt 2), p.124919-124919, Article 124919
issn 0141-8130
1879-0003
language eng
recordid cdi_proquest_miscellaneous_2815246565
source Elsevier ScienceDirect Journals
subjects Chitosan nanoparticle
Cytotoxicity
Ionic-gelation
Magnetic nanoparticle
MTT assay
Sorafenib
title Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T15%3A09%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chitosan%20based%20sorafenib%20tosylate%20loaded%20magnetic%20nanoparticles:%20Formulation%20and%20in-vitro%20characterization&rft.jtitle=International%20journal%20of%20biological%20macromolecules&rft.au=Dahiya,%20Mandeep&rft.date=2023-07-01&rft.volume=242&rft.issue=Pt%202&rft.spage=124919&rft.epage=124919&rft.pages=124919-124919&rft.artnum=124919&rft.issn=0141-8130&rft.eissn=1879-0003&rft_id=info:doi/10.1016/j.ijbiomac.2023.124919&rft_dat=%3Cproquest_cross%3E2815246565%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2815246565&rft_id=info:pmid/37196717&rft_els_id=S0141813023018135&rfr_iscdi=true